Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from Computation of Net Loss Per Share (Details)

v3.24.2.u1
Note 11 - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from Computation of Net Loss Per Share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Employee and Non-employee Stock Options [Member]        
Antidilutive Securities (in shares) 4,859,271 3,643,513 4,859,271 3,643,513
Warrant [Member]        
Antidilutive Securities (in shares) 0 205,000 0 205,000
Deferred Share Units [Member]        
Antidilutive Securities (in shares) 284,886 213,905 284,886 213,905
Restricted Stock Units (RSUs) [Member]        
Antidilutive Securities (in shares) 11,828 8,578 11,828 8,578